SEI Investments
PROF

SEI Investments’s Profound Medical PROF Stock Holding History

SEI Investments’s Portfolio PROF Stock Details PROF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-49,463
Closed -$389K – 3310
2025
Q4 		$389K Buy
+49,463
New +$318K ﹤0.01% 2618

Other funds holding PROF

Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
TIM
Timelo Investment Management Aurora, Ontario, Canada $127M AUM 23.73% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
GA
Gagnon Advisors New York $136M AUM 21.55% 1-Year Est. Return
LBA
Letko, Brosseau & Associates Montreal, Quebec, Canada $6.2B AUM 38.92% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
ZCP
Z3 Capital Partners Richmond, Virginia $395M AUM
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return

SEI Investments's PROF Position: Q1 2026 in Review

SEI Investments sold out of Profound Medical (PROF) in Q1 2026, closing a stake of 49,463 shares — an estimated $389K sold.

SEI Investments first reported a position in PROF in Q4 2025 and held it in 1 quarter. The position peaked at $389K in Q4 2025. 57 funds tracked by Wall St. Rank hold PROF as of Q1 2026.

  • SEI Investments reported no remaining Profound Medical position as of Q1 2026 after selling out during the quarter.
  • SEI Investments sold 49,463 Profound Medical shares in Q1 2026, an estimated $389K.
  • SEI Investments first reported a position in Profound Medical in Q4 2025 and held it in 1 quarter.
  • SEI Investments's Profound Medical position peaked at $389K in Q4 2025.
  • 57 funds tracked by Wall St. Rank held Profound Medical as of Q1 2026.

Based on SEI Investments's 13F filing for Q1 2026, filed 13 May 2026.